Please login to the form below

Free Thinking: Are biosimilars the answer to the rising cost of RA treatment?


In a past Free Thinking paper, we looked at the opportunity and challenges for biosimilar mAbs entering the rheumatoid arthritis market. A few years later and according to our Therapy Watch patient record data, uptake of biosimilars remains relatively muted, with marked inconsistencies across the major European markets. With Enbrel biosimilar Benepali about to launch across EU, we ask what’s next for RA?

http://www.researchpartnership.com/news/2016/04/ft-are-biosimilars-the-answer-to-the-rising-cost-of-...


3rd June 2016

Share

Tags

Company Details

Research Partnership

+44 (0)20 8069 5000

Contact Website

Address:
Chester House
Fulham Green
81-83 Fulham High Street
London
SW6 3JW
United Kingdom

Latest content on this profile

A safe place to talk about Crohn’s
Published in eyeforpharma April 2017 by Mariel Metcalfe
Research Partnership
Patient Assistance Programme Evaluation for Cardiovascular Conditions

Research Partnership
What next for the treatment of Psoriasis in Europe?
Research Director Laurent Chanroux investigates the changing market dynamics in Psoriasis in Europe.
Research Partnership
20 questions: Round 1

Research Partnership
Brand tracking research

Research Partnership
Pharma China Annual Forum 2017
We are delighted to be presenting a paper at the Pharma China Annual Forum on 14th April 2017 in Shanghai, China.
Research Partnership